Summary
Pharmaceutical company Lupin has received USFDA approval for its Modafinil tablets, intended to treat excessive sleepiness in adults. The drug is bioequivalent to Nuvo Pharmaceuticals' Provigil Tablets and had estimated annual sales of USD 70.7 million in the US.